التفاصيل البيبلوغرافية
| العنوان: |
Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice |
| المؤلفون: |
Wouters, Kristiaan, Bilsen, Marc van, Gorp, Patrick J. van, Bieghs, Veerle, Lütjohann, Dieter, Kerksiek, Anja, Staels, Bart, Hofker, Marten H., Shiri-Sverdlov, Ronit |
| المصدر: |
FEBS Letters; Mar2010, Vol. 584 Issue 5, p1001-1005, 5p |
| مصطلحات موضوعية: |
CHOLESTEROL, LIVER diseases, LOW density lipoproteins, ADENOSINE triphosphate, CYTOCHROME P-450, LABORATORY mice, ACETYL-CoA acyltransferase, PROGNOSIS |
| مستخلص: |
Abstract: Hepatic inflammation is the key factor in non-alcoholic steatohepatitis (NASH) and promotes progression to liver damage. We recently identified dietary cholesterol as the cause of hepatic inflammation in hyperlipidemic mice. We now show that hepatic transcriptome responses are strongly dependent on cholesterol metabolism during diet-induced NASH and its inhibition by fenofibrate. Furthermore, we show that, despite doubling hepatic steatosis, pharmacological LXR activation reverses hepatic inflammation, in parallel with reversing hepatic cholesterol levels. Together, the results indicate a prominent role of cholesterol during the development, inhibition and reversal of hepatic inflammation in NASH and reveal potential new therapeutic strategies against NASH. [Copyright &y& Elsevier] |
|
Copyright of FEBS Letters is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder